BEST TRIAL(redirected from BESTent TRIAL)
BEST TRIALA trial comparing long-term clinical and angiographic results of the BeStent and Palmaz-Schatz stent in native coronary lesions.
6-month major acute coronary events (MACE).
The BeStent is at least as safe and effective as the Palmaz-Schatz, with lower rates of target vessel and target lesion revascularisation; both cohorts had binary restenosis rates comparable to other stents.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.